Seasoned Clinical Data Management professional with thirty years of extensive experience in managing large-scale Phase2-3 studies and Registries with current focus in the Rare Disease space. I’ve had the privilege of contributing to multiple drug approvals. In addition to my technical expertise, I have successfully built and led Data Management teams from the ground up, and I thrive in developing strong relationships with my CRO partners through strategic oversight. My hands-on approach, leadership, and passion for driving data quality and integrity have allowed me to consistently ensure regulatory compliance and smooth execution of clinical trials.
Achievements:
Contributor of clinical data management expertise in support of Amicus Pompe NDA
Represented Clinical Data Management during pivotal FDA and PMDA inspections with no major findings
Developed data management teams to include senior level data management leads overseeing an outsourcing model of CROs and specialized vendors
Professional Membership & Accreditation
Four NDA Approvals
Data Privacy Champion
Mental Health First Aider
SCDM Membership
PAIR Fellow
Fun Fact
I love to do interior design as a hobby
My favorite movies are sci-fi and horror films
Muhammad Dzulkifli has been working in the hospitality industry for over 22 years.
With experience ranging from the following:
• Coffee House operations for York Hotel
• Banquet operations for Four Seasons Hotel
• Room service operations for Shangri-La Hotel and Swissotel the Stamford
• Fine dining operations for Les Amis and Orient Express Singapore
• Cafe operations for Venezia Café, Starbucks and Orient Express Singapore
• Restaurant operations for Olio Dome and The Coffee Connoisseur
• Bar operations for Harry’s Bar, Alley Bar, Our Bar and Orient Express Singapore
• Club operations for Cafe Del mar SG, Helipad SG, Ce La Vi SG and Bar Rouge SG
• Revenue management (Food and Beverage) for Swissotel the Stamford & Fairmont Singapore
• Revenue management (Food and Beverage) for Millennium Hotel & Resorts
The love for man-managing with discipline, awareness, flexibility and staff development has kept him devoted
and focus on creating a balance lifestyle for his colleagues via his unique interaction and policy making on
the ground.
Graduated with a Diploma in Child Psychology and Learning Disorders as well as a Diploma in Social Science
(Counselling) his main passion in coaching and talk therapy has develop his ability to blend work and play
due to his empathical approach and clarity of any given situation
Anne McPhee, SVP Global Asset Development and Operations at Worley Consulting, is an experienced leader with a deep knowledge of global energy, fuels, and chemicals markets grounded in a strong technology background. She is committed to working with our customers clients to optimize strategic decision making and to drive asset and operations transformation while navigating rapidly changing markets.
Steve held senior managements position with both asset owners and consultancy organizations and now leads initiatives within multiple major utilities to transform asset and operations management, including the design and implementation of new structures, decision making frameworks, policy and governance frameworks to increase organisational capability, as well as managing the necessary business change/transformation.
Clayton Ludik is the Vice President of Digital Consulting at Worley, leading a team of 150 specialists driving digital and automation modernization and transformation across industrial operating assets. With two decades of experience in engineering, R&D, and technology modernisation, Clayton brings a practical, ROI-focused approach to helping clients realise their ‘asset of the future’ aspirations.
Dr. Erin (Meyer) Goodhue, DO, MPH, is Director of Transfusion and Apheresis Services at The Ohio State University Wexner Medical Center. She brings 20+ years of leadership across academic medicine, pediatric care, industry, and global research. Prior to her current role, Dr. Goodhue served as Director of Global Clinical Research at Terumo BCT and held clinical leadership roles at Nationwide Children’s Hospital and the American Red Cross. She earned her DO from the University of New England, an MPH from Dartmouth, and completed faculty appointments at Harvard, Emory, and Dartmouth.
Dr. Kate Rochlin has served as IN8bio’s Chief Operating Officer since December 2021 and previously as their VP, Operations and Innovation. She has 19+ years of expertise in strategic company development & operations, IP, CMC, and Clinical manufacturing of advanced therapies. She was previously the Chief Business Officer at Curadigm, a Cambridge-based spin-out of Nanobiotix focused on RNA therapeutic bioavailability. Prior, Dr. Rochlin co-founded and served as CSO at Immunovent in New York City. Dr. Rochlin earned a Ph.D. in Molecular Biology and Genetics from Weill Cornell Medical College, researched at Sloan Kettering Institute, and a BA from the University of Pennsylvania.
Bernadette Wesdorp is a Partner in our Netherlands Leadership team and is the Responsible AI Netherlands Leader. She joined EY in November 2014 and, previously, was an IT consultant at a large telecommunications company.
Bernadette graduated from the Vrije Universiteit in Amsterdam with a Master of Science in Consulting & Communication. She is a Certified Information Privacy Professional (CIPP/e) from the International Association of Privacy Professionals (IAPP).
Bernadette is passionate about creating multidisciplinary, diverse, and inclusive teams, and is known for connecting the right people to the right clients. Bernadette is always looking for ways to help clients achieve their goals.
Dr. Ortega holds a doctorate in Molecular Biology and Analytical Chemistry from the University of Hawaii at Manoa. With a strong background in mass spectrometry, she serves as the Associate Director of Analytical Services at TriLink Biotechnologies. As part of the Analytical Development team, Dr. Ortega specializes in the physicochemical analysis of mRNA, oligonucleotides (i.e. gRNA), and small molecules such as NTPs and CleanCap® analogs. Her commitment to analytical excellence, combined with her scientific expertise, drives the development of robust methodologies to effectively fulfill client analytical requests and expand TriLink’s portfolio of analytical testing services.
Dr. Cody Palumbo is a Senior Application Scientist in Technical Design at TriLink BioTechnologies, where he partners with customers to support gRNA, oligonucleotide, and gene editing workflows by providing technical guidance and customized solutions. He brings deep expertise in CRISPR-based technologies and therapeutic development, drawing on years of experience across biotech and pharmaceutical settings. Prior to TriLink, Dr. Palumbo served as Associate Director of Gene Editing Process Development and Tech Transfer at Sana Biotechnology and led a team of Process Development scientists at Bristol Myers Squibb focused on gene editing tools for cell therapies. He holds a Ph.D. in Chemistry from the University of California, Davis. Dr. Palumbo is passionate about bridging technical innovation with real-world impact and frequently speaks on the evolving landscape of genome editing technologies.
